Your browser doesn't support javascript.
loading
Randomized, placebo controlled, double blinded pilot superiority phase 2 trial to evaluate the effect of curcumin in moderate to severe asthmatics.
Quan, Michele; Alismail, Abdullah; Daher, Noha; Cleland, Derrick; Chavan, Sonia; Tan, Laren D.
Affiliation
  • Quan M; Department of Medicine, School of Medicine, Loma Linda University Health, Loma Linda, CA, USA.
  • Alismail A; Department of Medicine, School of Medicine, Loma Linda University Health, Loma Linda, CA, USA.
  • Daher N; Department of Cardiopulmonary Sciences, School of Allied Health Professions, Loma Linda University Health, Loma Linda, CA, USA.
  • Cleland D; Allied Health Studies, School of Allied Health Professions, Loma Linda University Health, Loma Linda, CA, USA.
  • Chavan S; Department of Medicine, School of Medicine, Loma Linda University Health, Loma Linda, CA, USA.
  • Tan LD; La Sierra University, Riverside, CA, USA.
BMC Pulm Med ; 21(1): 268, 2021 Aug 17.
Article in En | MEDLINE | ID: mdl-34404358

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 / 4_TD Database: MEDLINE Main subject: Asthma / Immunoglobulin E / Curcumin / Eosinophils / COVID-19 / COVID-19 Drug Treatment Type of study: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies Limits: Adult / Female / Humans / Male Language: En Journal: BMC Pulm Med Year: 2021 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 / 4_TD Database: MEDLINE Main subject: Asthma / Immunoglobulin E / Curcumin / Eosinophils / COVID-19 / COVID-19 Drug Treatment Type of study: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies Limits: Adult / Female / Humans / Male Language: En Journal: BMC Pulm Med Year: 2021 Document type: Article